Geftinat 250mg Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Gefitinib (250mg)
Overview Geftinat 250mg Tablet
Igefinib 250mg tablets treat advanced non-small cell lung cancer. This medication is prescribed for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer therapy. Dosage should strictly follow your physician's instructions, continuing treatment as directed. Treatment length depends on individual response and needs. Your doctor may recommend regular liver function tests during treatment. Common side effects are diarrhea, xerosis, anorexia, and nausea. Increased fluid intake may lessen side effects. Report any concerning or worsening side effects to your doctor immediately. Mouth sores, visual disturbances, or respiratory problems warrant immediate medical attention. Women undergoing treatment must use reliable contraception; pregnancy should be avoided throughout treatment and for one month afterward. Always inform your physician of all other medications you are currently using.
Uses of Geftinat 250mg Tablet
Lung cancer (non-small cell type)
Major Benefits of Geftinat 250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 250mg Geftinat tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency in timing is recommended.
Common Side effects of Geftinat 250mg Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Geftinat 250mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; do not crush, chew, or break it. Geftinat 250mg tablets can be administered with or without food, however, consistent timing is recommended.
How Geftinat 250mg Tablet works:
Iclusig 250mg tablets are a cancer treatment. Their mechanism involves inhibiting a protein that triggers uncontrolled cancer cell growth, thereby hindering or slowing tumor progression.
SAFETY ADVICE
AlcoholUNSAFE
Combining Geftinat 250mg tablets and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Geftinat 250mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Geftinat 250mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of 250mg Geftinat tablets.
KidneyCAUTION
Iressa 250mg tablets require careful administration in patients exhibiting severe renal impairment. Dosage modification for Iressa 250mg tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of 250mg Geftinat tablets in patients with liver impairment is likely safe. Available evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Geftinat 250mg Tablet :
Omit any missed 250mg Geftinat Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Geftinat 250mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline amines |
| Developing Habits | No. |
| Type of Treatment | Cancer Medications |
3,018 People bought this recently